Stockscreener 앱 받기
250.55
0.46%
-0.8284
전일 마감가:
$251.38
열려 있는:
$251.43
하루 거래량:
226.97K
Relative Volume:
0.26
시가총액:
$18.04B
수익:
$2.96B
순이익/손실:
$487.70M
주가수익비율:
37.53
EPS:
6.6758
순현금흐름:
$344.00M
1주 성능:
+0.94%
1개월 성능:
+5.56%
6개월 성능:
+1.08%
1년 성능:
+10.93%
1일 변동 폭
$249.60
$254.60
1주일 범위
$244.91
$254.60
52주 변동 폭
$187.43
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
250.48 | 18.10B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
504.43 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.70 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.61 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.17 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.42 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
William Blair Investment Management LLC Trims Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by American Century Companies Inc. - MarketBeat
Transitioning your drug from a vial to combination product - Fierce Biotech
West Pharmaceutical Services, Inc. Announces Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
West Pharmaceutical (WST) SVP granted 1,285 RSUs and 3,057 options - Stock Titan
West Pharmaceutical (NYSE: WST) CEO granted new RSUs and stock options - Stock Titan
WEST PHARMACEUTICAL (WST) HR chief granted RSUs and stock options - Stock Titan
West Pharmaceutical SVP granted RSUs and options | WST SEC FilingForm 4 - Stock Titan
West Pharmaceutical (NYSE: WST) CFO awarded new RSUs and stock options - Stock Titan
West Pharmaceutical (WST) SVP awarded restricted stock units and options - Stock Titan
West Pharmaceutical Services Margins Slip To 16.3% Raising Questions Around Bullish Growth Narratives - Sahm
West Pharmaceutical (WST) VP, CAO receives RSU and stock option grants - Stock Titan
Champlain Investment Partners LLC Boosts Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
West Pharmaceutical Services : 2025 Annual Report (2490a2) - marketscreener.com
West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Promising 25% Upside Potential - DirectorsTalk Interviews
West Pharmaceutical Services, Inc. $WST Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
APG Asset Management N.V. Sells 244,966 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services (WST) Pricing Too Much Growth Into Its Current Share Price? - Yahoo Finance
West Pharmaceutical Services Inc (MIL:1WST) Stock Price, Trades & News - GuruFocus
Findlay Park Partners LLP Has $210.42 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Why West Pharmaceutical (WST) Is Up 5.5% After New US$1 Billion Buyback And Dividend Increase - Yahoo Finance
WST PE Ratio & Valuation, Is WST Overvalued - Intellectia AI
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Watch West Pharmaceutical’s March investor conference talks online - Stock Titan
Citigroup Inc. Has $21.71 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Declares Dividend, Authorizes $1B Buyback - MyChesCo
TD Asset Management Inc Has $159.06 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services: Demand Is Outrunning Supply—Can Capacity Investments Close the Gap? - Smartkarma
Why West Pharmaceutical Services (WST) is a Top Momentum Stock for the Long-Term - sharewise.com
West Pharmaceutical Services promotes COPHEX Korea presence - Traders Union
JPMorgan Chase & Co. Grows Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
How Investors Are Reacting To West Pharmaceutical Services (WST) New US$1 Billion Buyback And Dividend - Sahm
Aug Highlights: Will West Pharmaceutical Services Inc outperform small cap indexesFed Meeting & Long Hold Capital Preservation Tips - baoquankhu1.vn
Deadline Soon: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact The Law - EIN News
Here is Why West Pharmaceutical Services, Inc. (WST) is Strongly Favored by Hedge Funds - Finviz
Generation Investment Management LLP Sells 189,763 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Are Wall Street analysts bullish on West Pharmaceutical Services stock? - MSN
BofA Cuts West Pharmaceutical (WST) Target Following Model Update and Sector Pressure - Bitget
West Pharmaceutical (WST) SVP converts RSUs and withholds shares for taxes - Stock Titan
West Pharmaceutical (NYSE: WST) officer converts RSUs and withholds shares for taxes - Stock Titan
West Pharmaceutical Services connects with experts at BIO China event - Traders Union
Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 32.33%: Read This Before Placing a Bet - Finviz
Weekly Earnings: How sensitive is West Pharmaceutical Services Inc to inflation2025 Market Outlook & Verified High Yield Trade Plans - baoquankhu1.vn
How sensitive is West Pharmaceutical Services Inc. to inflationGold Moves & Weekly Breakout Watchlists - mfd.ru
West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth - Insider Monkey
Vanguard Group Inc. Buys 388,144 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by ICICI Prudential Asset Management Co Ltd - MarketBeat
Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock? - Yahoo Finance
Customer Concentration Risk: How Dependence on Key Accounts Threatens West Pharmaceutical’s Financial Stability - The Globe and Mail
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.07%
0.04%
자본화:
|
볼륨(24시간):